在KCNJ3中出现的新变异与早期发作的有关
Juan Li1,2,3, Shiyue Mei4, Xiao Mao5,6
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Journal of medical genetics
|November 14, 2023
概括
新的研究确定了与早期相关联的KCNJ3基因中的功能丧失变异. 对KCNJ3突变的基因测试为个性化治疗策略提供了一条道路.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- KCNJ3基因编码G蛋白结合的内向整形通道的一个子单元.
- 这些通道对于细胞刺激性和抑制性神经递质至关重要.
- 中KCNJ3的遗传基础在很大程度上仍未被探索.
研究的目的:
- 在被诊断为的个体中识别致病性KCNJ3变异.
- 调查已识别的KCNJ3变异对通道活动的功能影响.
- 为了确定KCNJ3突变和病病因之间的潜在联系.
主要方法:
- 整个外体序列测序被用来检测遗传变异.
- 具有KCNJ3变异的个体被招募用于全面的临床和遗传分析.
- 进行了电生理学研究,特别是全细胞补丁记录,以评估变体功能.
主要成果:
- 在两个不相关的家族中,确定了KCNJ3的两个de novo误解变异 (p.Leu333Ser和p.Arg313Gln).
- 生物信息学分析预测这些变异是有害的,并且它们不在人口数据库中.
- 功能测试表明,这些KCNJ3变异导致了显著的功能丧失效应.
结论:
- 在KCNJ3中,新的功能丧失变体与早期发作的有关.
- 对KCNJ3的基因查为治疗的精准医学提供了潜在的战略.
- 这些发现强调KCNJ3是导致的新型遗传因素.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318
Seizures: Classification
378
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
378
Antiepileptic Drugs: Potassium Channel Activators
191
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
191
Antiepileptic Drugs: Sodium Channel Blockers
610
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
610
Antiepileptic Drugs: GABAergic Pathway Potentiators
423
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
423
Antiepileptic Drugs: Glutamate Antagonists
382
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
382


